Serum HDL-cholesterol is associated with the clinical-biological profile of early-stage Parkinson’s disease patients independently of APOE

Mascioli D, Conti M, Bissacco J, Bovenzi R, Simonetta C, Buttarazzi V, Mancini M, Bagetta S, Sancesario GM, Maftei D, Veltri F, Marchionni E, Stefani A, Mercuri NB, Pieri M, Schirinzi T.